FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/06/043080 [Registered on: 08/06/2022] Trial Registered Prospectively
Last Modified On: 07/06/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Study of Vranashodhak Lepa For the Management Of Infected wound 
Scientific Title of Study   Randomized Open Controlled Clinical Study On The Role Of Vranashodhak Lepa In The Management Of Dushtavrana with special Reference To Infected Wound 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Prtibha Uttareshwar Surawase 
Designation  PG Scholar 
Affiliation  Dr SUYOG PATIL 
Address  Yashwant Ayurved College,Kodoli,Tal.Panhala,Dist.Kolhapur
Yashwant Ayurved College,Kodoli,Tal.Panhala,Dist.Kolhapur
Kolhapur
MAHARASHTRA
416114
India 
Phone  07028921994  
Fax    
Email  pratusurwase96@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Suyog Patil 
Designation  Associate Professor, Yashwant Ayurvedic College PGT and RC Kodoli 
Affiliation  Yashwant Ayurvedic College PGT and RC Kodoli 
Address  OPD no 4,Shalyatantra Department, Yashwant Ayurved College PGT and RC Kodoli,Tal.Panhala,Dist.Kolhapur
OPD no 4,Shalyatantra Department, Yashwant Ayurvedic College PGT and RC Kodoli, Tal Panhala, Dist Kolhapur
Kolhapur
MAHARASHTRA
416114
India 
Phone  07028921994  
Fax    
Email  drsuyog0222@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Pratibha uttareshwar surawase 
Designation  PG Scholar 
Affiliation  Dr Suyog Patil 
Address  Yashwant Ayurved College Kodoli Dist Kolhapur
At post Kodoli Dist Kolhapur
Kolhapur
MAHARASHTRA
416114
India 
Phone  7028921994  
Fax    
Email  pratusurwase96@gmail.com  
 
Source of Monetary or Material Support  
Prtibha Surawase 
Shalyatantra Department Yashwant Ayurved College and Hospital Kodoli Tal Panhala Dist Kolhapur 416114 
 
Primary Sponsor  
Name  Dr Prtibha Surawase 
Address  At post Kodoli Taluka Panhala Dist Kolhapur 416114 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Suyog Patil  At post Kodoli Taluka Panhala Dist Kolhapur416114 
Prtibha Surawase  At post Kodoli Taluka Panhala Dist kolhapur 416114 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Prtibha Surwase  Yashwant Ayurved College PGT and RC Kodoli  Department of shalyatantra, 3rd floor
Kolhapur
MAHARASHTRA 
7028921994

pratusurwase96@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Yashwant Ayurvedic College Kodoli  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L088||Other specified local infections of the skin and subcutaneous tissue. Ayurveda Condition: DUSHTAVRANAH, (2) ICD-10 Condition: L088||Other specified local infections of the skin and subcutaneous tissue, (3) ICD-10 Condition:L768||Other intraoperative and postprocedural complications of skin and subcutaneous tissue. Ayurveda Condition: DUSHTAVRANAH,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Povidone iodine ointment  Local application of povidone iodine of thickness 0.5cm on alternate day for 20 days  
Intervention  Vranashodhak Lepa  Local application of vranashodhak lepa of thickness 1cm on alternate day for 20 days 
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Wounds with slough and foul smell
Size of wound-lenght and breathe 2to10cm
Depth upto 1cm
Controlled Diabetic Wounds 
 
ExclusionCriteria 
Details  Wounds with excessive loss of tissues
Tuberculous ulcers
Venous ulcers
Malignant ulcers
Burns
Known case of HIV and HBsAg positive patients 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Slough
Smell
Pain
Swelling 
For 10 days 
 
Secondary Outcome  
Outcome  TimePoints 
Size of wound
Granulation tissue 
For next 10 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   09/06/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="15" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [pratusurwase96@gmail.com].

  6. For how long will this data be available start date provided 15-03-2021 and end date provided 25-12-2022?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   The Thesis is Randomised Open Controlled Clinical Study on the Role of Vranashodhak Lepa in the Management Of Dushtavrana with special Reference to Infected Wound
Control group drug is povidone iodine ointment
 
Close